April 29, 2025 03:46 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Canada: Indian student Vanshika, who went missing for past few days, found dead | J&K govt closes 48 tourist locations as intel warns of more terror attacks after Pahalgam incident | Mark Carney leads Liberal Party to victory in Canada, Khalistan sympathiser Jagmeet Singh bites dust | India calls Pakistan 'a rogue state fuelling global terrorism' at UN amid rising border tension after Pahalgam attack | Pahalgam terror attack hollowed all of us from core: Omar Abdullah | Jammu and Kashmir Assembly passes resolution, condemns Pahalgam attack | Stalin reshuffles Tamil Nadu cabinet after Senthil Balaji and Ponmudi's resignations | Centre blocks 16 Pakistani YouTube channels for provocative content in wake of Pahalgam terror attack | Centre blocks 16 Pakistani YouTube channels for provocative content in wake of Pahalgam terror attack | 'Work towards a responsible resolution': US to India and Pakistan over border tension after Pahalgam terror attack
AstraZeneca
Pixabay

Indonesia pauses AstraZeneca Vaccination over health concerns:  Regulator

| @indiablooms | Mar 16, 2021, at 03:03 pm

Moscow/Sputnik: The Indonesian Food and Drug Authority (BPOM) has decided to hold up the use of the UK-Swedish AstraZeneca COVID-19 vaccine amid fears that the recipients may develop potentially deadly blood clots, BPOM head Penny Lukito said on Monday.

"We are communicating with the [World Health Organization] WHO and the [Strategic Advisory Group of Experts on Immunization] SAGE out of precautions. The results will then be submitted to inter-agency team and the Health Ministry who will then decide whether AstraZeneca vaccine can be used in the national vaccination drive," Penny said, as quoted by the Jakarta Globe newspaper.

The BPOM chief expressed hope that it would not take long for the final say on the matter.

According to the media outlet, Indonesia received 1.1 million doses of the AstraZeneca vaccine last week through the WHO-led COVAX international distribution initiative.

WHO is expected to hold a meeting on the safety of the AstraZeneca coronavirus vaccine on Tuesday.

AstraZeneca said on Sunday that it had found no evidence of increased risk of blood clots from its COVID-19 vaccine after conducting a careful review of safety data of over 17 million inoculated people across the European Union and the United Kingdom. In the meantime, France, Germany, Italy, Denmark, Estonia, Iceland, Latvia, Lithuania, Luxemburg and Norway have temporarily suspended the use of the AstraZeneca vaccine after citizens reported side-effects following inoculation from the vaccine's ABV5300 batch.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu